Skip to content
×

Director, Early Value Lead

Listing for: our future Intern
Full Time, Part Time position Listed on 2026-11-16
Job specializations:
Salary/Wage Range or Industry Benchmark: 230400 - 345600 USD Yearly USD 230400.00 345600.00 YEAR

Job Description & How to Apply Below

The base salary range for this position is $230,400 to $345,600. The position may be eligible for a role specific discretionary bonus, relocation, and/or other compensation elements. We continuously review market data and may adjust salary ranges as needed in the future. Actual compensation will be based on job-related factors such as skills, experience, and qualifications, and other factors permitted by law.

For an overview of our benefits please  .

Description

As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development, and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in several ways to foster a healthy working environment, meaningful work, mobility, networking, and work-life balance.

Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.

This role is based on-site at our Ridgefield, CT location with hybrid flexibility of 2-3 days per week on-site.

The Director, Early Value Lead (eVL) is responsible for making key strategic decisions for the development of the US Early Value Strategy for assigned therapeutic areas.

The eVL will create asset or indication-specific US Early Value Strategies that maximize price & reimbursement, market share, sales, and profitability. The eVL will do this by executing pricing research, market access assessments, defining optimized launch sequencing and co-development of payor value propositions that illustrate the value of the product.

The role will require leadership to ensure Value perspectives from the US market are incorporated into deliverables such as the Asset Evidence Plan, Target Product Profile (TPP) and Integrated Asset Plan (IAP) and that those perspectives brought forward to corporate colleagues then drive co-creation of the early asset development strategy with the Global Asset Team.

They will be responsible for collaborating with multiple functional groups as part of their knowledge network, including but not limited to Marketing, Medical, Clinical Development, HEOR, Regulatory, Finance, Competitive Intelligence, Forecasting, Analytics, and Insights, Legal, Public Policy and Global Market Access teams, to define and execute on asset team strategic and operational deliverables.

Additionally, the eVL is responsible for development and ongoing assessment of the overall Gross to Net pricing strategy for assets across one or more therapeutic areas in the US, across all channels beginning before Phase I via indication assessments through launch of an asset. This includes setting of WAC price and corresponding discounting/rebating strategies to estimate net price for forecasting.

Duties & Responsibilities
  • Develops indication specific US Early Value Strategies for assigned therapeutic areas containing early pricing, market access, optimized launch sequencing and payor value proposition strategy and including payer insights with IRA considerations to optimize likelihood of success for assets and indications in the U.S. Market.
  • Revises and updates strategy throughout the clinical development program as guided by the market access excellence framework.
  • Leads pricing strategy efforts for BIPI, in coordination with Corporate Market Access colleagues, including testing of eTPPs, understanding volume and access trade-offs and inclusion of receptivity and expectations among stakeholders to engage in innovative contracting strategies to inform forecasting assumptions.
  • Co-creates global deliverables such as Asset Narrative, Asset Evidence Plan, eTPPs, IAPs, and execution of local strategic and operational outputs such as Early Indication Assessments, Asset Maximization work streams, Channel Mix Assessment, Competitive Landscape, Patient Journey, Flow of the Dollar. etc. across major clinical development milestones for each asset and indication.
  • Collaborates with eAT Evidence and Team Lead as well as knowledge network including marketing, policy, HEOR, regulatory, finance, GTN, forecasting and corporate colleagues to capture relevant payor insights, identify data gaps, and through close alignment with evidence lead and HEOR, ensures evidence generation and pricing is aligned to a compelling value proposition.
  • Leads early…
To View & Apply for jobs on this site that accept applications from your location or country, tap the button below to make a Search.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).
View / Apply for Jobs
Matching My Jurisdiction

Search for further Jobs Here:

SEARCH JOBS: 10+ Million Listings
(Try combinations for better Results! Or enter less keywords for broader Results)
Education Level
Experience Level (years)
Posted in last:
Salary